About the Authors
- Laurentya Olga
-
Roles Data curation, Formal analysis, Writing – original draft
Affiliation Department of Obstetrics and Gynaecology and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
- Ulla Sovio
-
Roles Data curation, Formal analysis, Investigation, Writing – review & editing
Affiliation Department of Obstetrics and Gynaecology and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
- Hilary Wong
-
Roles Data curation, Formal analysis, Writing – review & editing
Affiliation Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom
- Gordon Smith
-
Roles Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliation Department of Obstetrics and Gynaecology and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
- Catherine Aiken
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: cema2@cam.ac.uk
Affiliation Department of Obstetrics and Gynaecology and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: GS has no direct conflict of interest. GS has received research support from Roche Diagnostics Ltd, Illumina and Sera Prognostics (fetal growth restriction, preeclampsia and preterm birth). GS’s department has received payment from Roche for a talk given by GS (fetal growth restriction). GS has been a paid consultant to GSK (preterm birth) and is a member of a Data Monitoring Committee for GSK trials of RSV vaccination in pregnancy. GS and US are two of three named inventors on a patent application (PCT/GB2020/053312) filed by Cambridge Enterprise for novel predictive test for fetal growth disorder. GS serves on PLOS Medicine’s editorial board. The other authors have no conflicts of interest including financial interests, activities, relationships, and affiliations to declare.